 CARLSBAD, Calif., Jan. 23, 2023 GLOBE NEWSWIRE Qualigen Therapeutics, Inc. Qualigen or the Company, Nasdaq: QLGN, a diversified life sciences company focused on developing treatments for adult and pediatric cancers with potential for Orphan Drug Designation, while also commercializing diagnostics, today announces the promotion of Benedict M. Abugan to Vice President, Head of Diagnostics... The post Qualigen Therapeutics Promotes Benedict M. Abugan to Vice President, Head of Diagnostics a... 